Kratom & Benzodiazepines: What Does Research Say?
If there is one substance combination discussed with particular seriousness in the kratom community, it is this one: kratom and benzodiazepines. Unlike some other combinations, there are concrete and consistent data here that call for caution.
What are benzodiazepines?
Benzodiazepines are a class of psychoactive substances used as anxiolytics, sedatives, hypnotics, muscle relaxants and anticonvulsants. Well known members are diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan) and clonazepam (Klonopin).
Their mechanism of action: benzodiazepines bind to GABAA receptors and amplify the inhibitory action of GABA, the most important inhibitory neurotransmitter in the central nervous system. The result is broad CNS depression.
Mitragynine: the mechanism in brief
Mitragynine acts primarily as a partial agonist at the μ-opioid receptor (MOR). Like classic opioids, mitragynine can contribute to sedation and CNS depression, particularly at higher amounts.
Where the interaction becomes critical
| System | Benzodiazepine | Mitragynine | Combination |
|---|---|---|---|
| GABAA receptors | Strongly activated | Little direct interaction | GABAergic component dominates |
| μ-opioid receptor | No direct action | Partial agonist | Opioid component additive |
| Respiratory depression | Possible, dose-dependent | Possible, dose-dependent | Potentially synergistic |
| Overall sedation | Strong | Dose-dependent | Additive to synergistic amplification |
The critical point: both substance classes can cause respiratory depression. When both mechanisms are activated at the same time, the risk of life-threatening respiratory depression is considerably higher than with either substance on its own.
What the data show
In analyses of the US FAERS database, benzodiazepines were among the substances most frequently co-involved in serious kratom-associated events and deaths. Several published case reports describe respiratory arrest or severe sedation following the combination. In some cases naloxone was at least partially effective.
Conclusion
Kratom and benzodiazepines are the combination against which research data warn most consistently. Two substance classes that can produce CNS depression and respiratory depression through different mechanisms should not be combined.
Important note: this article describes the scientific state of research only. It does not constitute a medical recommendation. Our products are not intended for consumption.
Further reading
- Kratom & Cannabis: Overlapping Receptor Systems?
- Kratom & Antidepressants (SSRIs/SNRIs): What Research Shows
- Kratom and Caffeine: What Does Research Say About the Combination?
- Kratom and Sleep: Withdrawal, REM Sleep and the State of Research
Legal notice
This article is for informational purposes only and does not constitute legal advice. Its content is not intended to encourage consumption. Laws may change; the applicable regulations and information from official bodies are authoritative. Image source: https://www.kratoein.com/